TROP-2 as a promising ADC target in penile squamous cell carcinoma that promotes cell proliferation by activating AKT through PKCa pathway

被引：0
|
作者：
Tang, Y.
Yao, K.
Tan, X.
Wei, W.
Zhou, Q. [1 ]
机构：
[1] Sun Yat Sen Univ, Dept Urol, Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.2072
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1987P
引用
收藏
页码：S1149 / S1149
页数：1
相关论文
共 50 条
  • [1] Trop-2: A promising new therapeutic target in penile squamous cell carcinoma.
    Weiten, Richard
    Kessler, Carolina
    Spohn, Hanna Elisa
    Storz, Enno
    Pfister, David A.
    Nestler, Tim
    Tolkach, Yuri
    Wirtz, Ralph M.
    von Brandenstein, Melanie
    Krausewitz, Philipp
    Heidenreich, Axel
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL)
  • [2] The role of TROP-2 in the progression and target therapy in penile squamous cell carcinoma
    Tang, Yi
    Tan, Xingliang
    Liu, Zhicheng
    Zhou, Qianghua
    Wei, Wensu
    Yuan, Gangjun
    Yao, Kai
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [3] TROP-2-A PROMISING NEW THERAPEUTIC TARGET IN PENILE SQUAMOUS CELL CARCINOMA
    Weiten, Richard
    Kessler, Carolina
    Meisl, Christina
    Spohn, Hanna Elisa
    Storz, Enno
    Pfister, David
    Nestler, Tim
    Tolkach, Yuri
    Linden, Friederike
    Wirtz, Ralph
    von Brandenstein, Melanie
    Krausewitz, Philipp
    Heidenreich, Axel
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1013 - E1013
  • [4] TROP-2-a promising new therapeutic target in penile squamous cell carcinoma
    Weiten, R.
    Kessler, C.
    Meisl, C.
    Spohn, H. E.
    Storz, E.
    Pfister, D.
    Nestler, T.
    Tolkach, Y.
    Linden, F.
    Wirtz, R.
    Von Brandenstein, M.
    Krausewitz, P.
    Heidenreich, A.
    EUROPEAN UROLOGY, 2024, 85 : S1149 - S1150
  • [5] TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway
    Shen, Peng
    Zhang, Tian-Yang
    Wang, Shu-Yan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (04)
  • [6] Trop-2 expression in vulvar squamous cell carcinoma (VSCC) - a possible target for the treatment approach with antibody drug conjugates (ADC)
    Horn, Lars-Christian
    Hoehn, Anne-Kathrin
    Aktas, Barhyhie
    Dornhoefer, Nadja
    Gilks, Blake
    Singh, Naveena
    Hoang, Lien
    Hiller, Ruth
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 97 - 98
  • [7] CDKN3 promotes cell proliferation, invasion and migration by activating the AKT signaling pathway in esophageal squamous cell carcinoma
    Yu, Hanxu
    Yao, Jun
    Du, Mingyu
    Ye, Jinjun
    He, Xia
    Yin, Li
    ONCOLOGY LETTERS, 2020, 19 (01) : 542 - 548
  • [8] PAR-2 promotes cell proliferation, migration, and invasion through activating PI3K/AKT signaling pathway in oral squamous cell carcinoma
    Tang, Kai-Liang
    Tang, Han-Ying
    Du, Yi
    Tian, Tian
    Xiong, Shi-Jiang
    BIOSCIENCE REPORTS, 2019, 39
  • [9] TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target
    Condic, Mateja
    Egger, Eva K. K.
    Kluemper, Niklas
    Kristiansen, Glen
    Mustea, Alexander
    Thiesler, Thore
    Ralser, Damian J. J.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8235 - 8241
  • [10] TROP-2 is widely expressed in vulvar squamous cell carcinoma and represents a potential new therapeutic target
    Mateja Condic
    Eva K. Egger
    Niklas Klümper
    Glen Kristiansen
    Alexander Mustea
    Thore Thiesler
    Damian J. Ralser
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 8235 - 8241
12345